Chemical activators of OTTMUSG00000010537 can influence the protein's activation state through various biochemical pathways. Forskolin is known to directly activate adenylyl cyclase, which catalyzes the conversion of ATP to cyclic AMP (cAMP), a critical second messenger in cellular signaling. The increase in cAMP levels leads to the activation of protein kinase A (PKA), a kinase that can phosphorylate and hence activate OTTMUSG00000010537. Similarly, Isoproterenol and Epinephrine, by binding to and activating beta-adrenergic receptors, stimulate adenylyl cyclase, increasing cAMP levels in the cell, and in turn activating PKA, which can then target OTTMUSG00000010537 for activation by phosphorylation. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), another kinase known to phosphorylate and activate multiple proteins, including OTTMUSG00000010537.
Additionally, IBMX functions by inhibiting phosphodiesterases which degrade cAMP and cyclic GMP (cGMP), thus increasing the levels of these signaling molecules that activate PKA and protein kinase G (PKG). Both kinases are capable of phosphorylating OTTMUSG00000010537, leading to its activation. Sildenafil, by specifically inhibiting phosphodiesterase type 5, increases cGMP levels, thereby activating PKG which can also phosphorylate OTTMUSG00000010537. Anisomycin, which activates stress-activated protein kinases, and ionomycin, which increases intracellular calcium levels and subsequently activates calcium-dependent kinases, both lead to the phosphorylation and activation of OTTMUSG00000010537. Okadaic Acid, by inhibiting protein phosphatases, prevents dephosphorylation and maintains proteins in a phosphorylated state, potentially keeping OTTMUSG00000010537 active. The cAMP analog 8-Br-cAMP and Calyculin A, which inhibits serine/threonine phosphatases, ensure the phosphorylated state of OTTMUSG00000010537, contributing to its continued activation. Lastly, Zaprinast inhibits phosphodiesterase types 5 and 6, leading to increased levels of cGMP and activation of PKG, which then can phosphorylate and activate OTTMUSG00000010537, completing the array of chemical activators that can upregulate the activity of this protein through their distinct but interrelated mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol binds to and activates beta-adrenergic receptors, which in turn stimulates adenylyl cyclase to raise intracellular cAMP levels, thereby activating PKA that can phosphorylate and activate OTTMUSG00000010537. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine engages with adrenergic receptors, leading to the activation of adenylyl cyclase and an increase in cAMP. This elevation of cAMP activates PKA, which phosphorylates and activates OTTMUSG00000010537. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA functions as an activator of protein kinase C (PKC), which upon activation can phosphorylate OTTMUSG00000010537, stimulating its activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, leading to increased levels of cAMP and cGMP, which can activate PKA and PKG. These kinases may phosphorylate and activate OTTMUSG00000010537. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases which can phosphorylate and activate OTTMUSG00000010537. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which activates calcium-dependent kinases capable of phosphorylating and activating OTTMUSG00000010537. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases 1 and 2A, leading to a net increase in protein phosphorylation, and potentially maintaining OTTMUSG00000010537 in an activated state. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
The cAMP analog 8-Br-cAMP activates PKA directly, which then phosphorylates and activates OTTMUSG00000010537. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits certain serine/threonine phosphatases, which would otherwise dephosphorylate target proteins, leading to an increase in the phosphorylated and activated form of OTTMUSG00000010537. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterase types 5 and 6, increasing cGMP levels, which activates PKG that subsequently phosphorylates and activates OTTMUSG00000010537. | ||||||